Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Works To Stay Focused As Heads Spin; Deputy Commissioners In Spotlight

Executive Summary

A key challenge for FDA following the resignation of Commissioner Lester Crawford will be overcoming the impression that being without a permanent leader yet again will result in a period of stasis at the agency

You may also be interested in...



FDA Gets Permanent Drug Safety Director In Advance Of Drug Center Overhaul

FDA's Office of Drug Safety will take on a higher profile position under a proposed reorganization of the Center for Drug Evaluation & Research

FDA Gets Permanent Drug Safety Director In Advance Of Drug Center Overhaul

FDA's Office of Drug Safety will take on a higher profile position under a proposed reorganization of the Center for Drug Evaluation & Research

Plan B Delay Draws Criticism From Congress, Academia, FDA Official

FDA's handling of Barr's application to switch Plan B over the counter could elicit heightened external scrutiny of the agency's ability to make drug approval decisions based solely on science and public health

Related Content

Topics

UsernamePublicRestriction

Register

PS046382

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel